Supporting the pharmaceutical salesforce with digital marketingAs marketers, we often wonder how we can best get our concept and product information to our customers, Share XSupporting the pharmaceutical salesforce with digital marketinghttps://pharmaphorum.com/views-and-analysis/supporting-the-pharmaceutical-salesforce-with-digital-marketing/
Tackling adherence is “only sustainable path to profit”Every year, pharmaceutical companies lose an eye-watering $637bn through medication non-adherence – so why isn’t the industry taking Share XTackling adherence is “only sustainable path to profit”https://pharmaphorum.com/views-analysis-sales-marketing/tackling-adherence-is-only-sustainable-path-to-profit/
How to keep innovating when roadblocks stand in your wayWith its position as one of the top 10 most–regulated industries in the US, pharma can pose a challenge to marketers eager Share XHow to keep innovating when roadblocks stand in your wayhttps://pharmaphorum.com/views-and-analysis/how-to-keep-innovating-when-roadblocks-stand-in-your-way/
Pfizer’s Pol Vandenbroucke on the changing industryAhead of the 2019 eyeforpharma Barcelona conference, we asked speaker Pol Vandenbroucke – chief medical officer of the Share XPfizer’s Pol Vandenbroucke on the changing industryhttps://pharmaphorum.com/views-analysis-sales-marketing/pfizers-pol-vandenbroucke-on-the-changing-industry/
JP Morgan Healthcare: where science, tech and finance collideWelcome to 2019! Hopefully by now you’re managing to ease yourself back into things, no doubt with good Share XJP Morgan Healthcare: where science, tech and finance collidehttps://pharmaphorum.com/views-analysis-sales-marketing/jp-morgan-healthcare-science-tech-finance-collide/
Brexit and beyond: the challenges ahead for pharmaBrexit, and the political fallout from approving any deal, will continue to dominate British politics in 2019. It Share XBrexit and beyond: the challenges ahead for pharmahttps://pharmaphorum.com/views-analysis-sales-marketing/brexit-challenges-ahead-pharma/
The constants of pharma marketingVeteran marketer Neal Wolff’s career has taken him from big pharma to US-based biotech Nevakar. We spoke to Share XThe constants of pharma marketinghttps://pharmaphorum.com/views-analysis-sales-marketing/the-constants-of-pharma-marketing/
The end of siloed healthcareFor the past eight years Syneos Health has been issuing annual healthcare trends forecasts, usually separated into Communications Share XThe end of siloed healthcarehttps://pharmaphorum.com/views-analysis-sales-marketing/the-end-of-siloed-healthcare/
2018 in review: Humira biosimilars arrive in EuropeThe emergence this year of Humira biosimilars in Europe followed a period of sustained momentum around the cheaper Share X2018 in review: Humira biosimilars arrive in Europehttps://pharmaphorum.com/views-analysis-sales-marketing/2018-review-humira-biosimilars-europe/
